In a positive development, Pune-based Serum Institute of India (SII) has already manufactured 40 million doses of the potential COVID-19 vaccine developed by Oxford University and...
read full article...
Serum Institute Completes At-Risk Manufacturing Of 40 Million Doses Of Oxford-AstraZeneca's Covishield Vaccine